Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty?
- PMID: 8411027
- PMCID: PMC1016454
- DOI: 10.1136/jmg.30.7.557
Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty?
Abstract
Opinions on the implications of predictive testing for Huntington's disease were evaluated in a group of 169 women (aged 21-35 years) with interest in psychosocial issues, but with no special pre-existing knowledge or training in genetics. Predictive testing for Huntington's disease (HD) is considered to be a test case for predictive testing for other late onset diseases, monogenic as well as multifactorial disorders. In the hypothetical situation of having a 50% risk for developing HD, about half of the group expressed interest in a predictive test. As to the question of giving results of predictive tests to third parties, the group would be very reluctant to inform the employer or the insurer, but not their own family. Prenatal testing for late onset diseases was considered acceptable by half of the women; only one quarter of the total group would terminate a pregnancy of a child that might develop a late onset disease. The assessment of attitudes towards predictive testing was carried out within the context of a global evaluation of perceived advantages and disadvantages of genetic counselling. The attitudes towards predictive testing were systematically associated with perceiving 'having more certainty about the future' as an advantage of genetic counselling and with rejecting 'knowing everything in advance' as a disadvantage.
Similar articles
-
Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.J Med Genet. 1993 Jul;30(7):549-56. doi: 10.1136/jmg.30.7.549. J Med Genet. 1993. PMID: 8411026 Free PMC article.
-
Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany.J Med Genet. 1993 Dec;30(12):1023-7. doi: 10.1136/jmg.30.12.1023. J Med Genet. 1993. PMID: 8133501 Free PMC article.
-
Psychosocial effects of predictive testing for Huntington's disease.Adv Neurol. 2005;96:226-39. Adv Neurol. 2005. PMID: 16383222 Review. No abstract available.
-
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.JAMA. 1993 Nov 17;270(19):2321-5. JAMA. 1993. PMID: 8230594
-
Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.Patient Educ Couns. 1998 Sep;35(1):15-26. doi: 10.1016/s0738-3991(98)00086-x. Patient Educ Couns. 1998. PMID: 9832893 Review.
Cited by
-
Patient perspectives of medical confidentiality: a review of the literature.J Gen Intern Med. 2003 Aug;18(8):659-69. doi: 10.1046/j.1525-1497.2003.20823.x. J Gen Intern Med. 2003. PMID: 12911650 Free PMC article. Review.
-
The ethics of type 1 diabetes prediction and prevention research.Theor Med Bioeth. 2003;24(2):177-97. doi: 10.1023/a:1024686511111. Theor Med Bioeth. 2003. PMID: 12943271
-
Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling.Transl Oncol. 2020 Sep;13(9):100799. doi: 10.1016/j.tranon.2020.100799. Epub 2020 May 22. Transl Oncol. 2020. PMID: 32450551 Free PMC article.
-
The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.J Genet Couns. 2006 Oct;15(5):375-91. doi: 10.1007/s10897-006-9033-8. Epub 2006 Sep 27. J Genet Couns. 2006. PMID: 17004133
-
Death anxiety and symbolic immortality in relatives at risk for familial amyloid polyneuropathy type I (FAP I, ATTR V30M).J Genet Couns. 2010 Dec;19(6):585-92. doi: 10.1007/s10897-010-9311-3. Epub 2010 Aug 3. J Genet Couns. 2010. PMID: 20680419
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials